Literature DB >> 30007510

Life-threatening DBS withdrawal syndrome in Parkinson's disease can be treated with early reimplantation.

S Reuter1, G Deuschl1, D Berg2, A Helmers3, D Falk3, K Witt4.   

Abstract

INTRODUCTION: The deep brain stimulation (DBS) withdrawal syndrome (DBS-WDS) is a rare, life-threatening complication in Parkinson's disease (PD) patients with long disease duration and stimulation when stimulation is terminated for extended periods mostly due to infection of the DBS-hardware. METHODS,
RESULTS: In five patients explantation became necessary because of infection after a mean of 11.4 years (range 4-15 years) of DBS and a mean disease duration of 24.6 years (range 3-22 years). Mean UPDRS motor-score pre-explantation was 38 points (range 24-55 points) which increased to a mean of 78.4 points (range 58-90 points) after explantation, despite optimal Levodopa dosing. Reimplantation of the hardware after 23 days (range 3-45 days) under antibiotic treatment led to an improvement to a mean of 40 points (range 25-73 points) and a complication free survival.
CONCLUSION: Early reimplantation of the DBS-hardware is a treatment option of the DBS-WDS when the life-threatening urgency overrides surgical standards. Observation of the syndrome indicates pharmacological unresponsiveness of the dopaminergic system in advanced PD and long-term DBS.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; Explantation; Life-threatening DBS withdrawal syndrome; Therapy

Mesh:

Year:  2018        PMID: 30007510     DOI: 10.1016/j.parkreldis.2018.06.035

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  Severe jaw-opening off-dystonia in Parkinson's disease masked by effective deep brain stimulation of the subthalamic nucleus.

Authors:  Francesco Bove; Carla Piano; Alfonso Fasano; Luigi Michele Romito; Maria Fiorella Contarino
Journal:  Neurol Sci       Date:  2021-11-26       Impact factor: 3.307

Review 2.  Evidence of Neuroplastic Changes after Transcranial Magnetic, Electric, and Deep Brain Stimulation.

Authors:  Julius Kricheldorff; Katharina Göke; Maximilian Kiebs; Florian H Kasten; Christoph S Herrmann; Karsten Witt; Rene Hurlemann
Journal:  Brain Sci       Date:  2022-07-15

3.  Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies.

Authors:  Anna Roszmann; Aleksandra M Podlewska; Yue Hui Lau; Iro Boura; Annette Hand
Journal:  Int Rev Neurobiol       Date:  2022-07-09       Impact factor: 4.280

4.  Treatment paradigms in Parkinson's Disease and Covid-19.

Authors:  Iro Boura; Lucia Batzu; Espen Dietrichs; Kallol Ray Chaudhuri
Journal:  Int Rev Neurobiol       Date:  2022-05-28       Impact factor: 4.280

5.  Letter: Evaluation and Surgical Treatment of Functional Neurosurgery Patients With Implanted Deep Brain Stimulation and Vagus Nerve Stimulation Pulse Generators During the COVID-19 Pandemic.

Authors:  Robert E Gross; Cathrin M Buetefisch; Svjetlana Miocinovic; Katie L Bullinger; Michael S Okun; Jill L Ostrem; Kelly D Foote; Phillip A Starr
Journal:  Neurosurgery       Date:  2020-08-01       Impact factor: 4.654

Review 6.  Recommendations for Deep Brain Stimulation Device Management During a Pandemic.

Authors:  Svjetlana Miocinovic; Jill L Ostrem; Michael S Okun; Katie L Bullinger; Patricio Riva-Posse; Robert E Gross; Cathrin M Buetefisch
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.